Join the Helicobacter Pylori Infection group to help and get support from people like you.
Helicobacter Pylori Infection News
Related terms: Pylori
15.6 Million Lifetime Gastric Cancers Expected in Those Born During 2008 to 2017
THURSDAY, July 10, 2025 – Among young people born in 2008 to 2017, 15.6 million lifetime gastric cancer cases are expected globally, with more than three-quarters attributable to Helicobacter...
Three-Quarters of Stomach Cancers Could Be Prevented By Targeting Helicobacter Pylori Bacteria
TUESDAY, July 8, 2025 — Three-quarters of stomach cancer cases could be prevented if doctors eradicate infection by a common type of bacteria, a new study says. The bacteria, Helicobacter pylori, is l...
Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
THURSDAY, March 6, 2025 – For patients with gastroesophageal reflux disease (GERD), those with Helicobacter pylori infection have significantly lower rates of symptom rebound and rebound severity...
Clinical Practice Guideline Developed for Treatment of H. Pylori Infection
MONDAY, Sept. 9, 2024 – In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of the American Journal of Gastroenterology,...
RedHill Announces FDA sNDA Approval for Simplified Dosage Regimen for Talicia
FDA approves supplemental new drug application (sNDA) for Talicia, changing dosing to a simplified three times daily (TID) regimen, which may support increased patient adherence and treatment...
FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 04, 2019 (GLOBE NEWSWIRE) – RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
Further information
Related condition support groups
Related drug support groups
amoxicillin, metronidazole, omeprazole, pantoprazole, Nexium, Flagyl, Pepto-Bismol, Prilosec, Protonix, clarithromycin, lansoprazole, tetracycline, esomeprazole